The $6 million settlement, plus 2 percent accrued interest, will be paid in nine quarterly installments beginning July 2013. The company admits no wrongdoing as part of the settlement.
Baxano will undertake compliance training and monitoring by HHS and the Office of Inspector General for five years.
More Articles on Devices:
Mexico Grants SpineGuard Clearance to Sell Cannulated PediGuard Device
Osimplant’s ARIA PLIF Device Available Globally
Mazor Robotics Receives First Renaissance Follow-Up Order
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
